ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

KLDO Kaleido Biosciences Inc (CE)

0.000001
-0.0001 (-99.00%)
18 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Kaleido Biosciences Inc (CE) USOTC:KLDO OTCMarkets Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.000099 -99.00% 0.000001 0.0001 0.000001 0.0001 1,912 20:37:00

Kaleidoscope Venture Capital Inc. - Current report filing (8-K)

15/07/2008 2:30pm

Edgar (US Regulatory)


UNITED STATES
 
SECURITIES AND EXCHANGE COMMISSION
 
Washington D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
 
 
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): July 14, 2008
 
KALEIDOSCOPE VENTURE CAPITAL INC.
 
(Exact name of registrant as specified in its charter)
 
Nevada
(State or other jurisdiction of incorporation)

000-27277
(Commission File Number)

98-0207554
(IRS Employer Identification No.)

170 E. Post Road, Suite 206
White Plains, New York 10601
(Address of principal executive offices)(Zip Code)

(914) 448-7600
Registrant’s telephone number, including area code

Vocalscape Networks, Inc.
(Former name or address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 

 
 
Item 3.03 Material Modification to Rights of Security Holders

Effective July 14, 2008, the Board of Directors and security holders representing a majority of the voting power of Kaleidoscope Venture Capital Inc., a Nevada corporation (the “Company”), approved an amendment to the Company’s Articles of Incorporation effecting a one-for-two hundred (1:200) reverse split of the Company’s issued and outstanding shares of common stock and Series A Convertible Preferred Stock. The Company’s authorized share capital, as stated in its Articles of Incorporation remains unchanged, effectively increasing the ratio of authorized shares of common stock and Series A Convertible Preferred Stock of the Company to the number of issued and outstanding shares of common stock and Series A Convertible Preferred Stock. As a result of the reverse stock split, each 200 shares of the Company’s common stock and Series A Convertible Preferred Stock issued and outstanding on such date represents one (1) share of the Company’s common stock. Fractional shares existing as a result of the reverse stock split were rounded up to the nearest whole share.
 
Item 5.03 Amendment to Articles of Incorporation or Bylaws; Change in Fiscal Year

Effective July 14, 2008, the Company amended its Articles of Incorporation to change its name from “Vocalscape Networks, Inc.” to “Kaleidoscope Venture Capital Inc.”

Effective July 14, 2008, the Company filed, with the Secretary of State of the State of Nevada, a Certificate of Change, effecting a one-for-two hundred (1:200) reverse split of the Company ‘s issued and outstanding shares of common stock and Series A Convertible Preferred Stock on such date. A description of the reverse stock split is disclosed in Item 3.03 of this Current Report on Form 8-K, which disclosure is incorporated herein by this reference.

Item 8.01 Other Events

“KLDO” is the Company’s new ticker symbol for its shares of common stock quoted on the Over-the-Counter Bulletin Board, in connection with its change of name to Kaleidoscope Venture Capital Inc.

Item 9.01 Financial statements and Exhibits

(d) Exhibits

The following exhibit is filed as part of this report:
 
No. Description
   
3.1.6
Certificate of Amendment
3.1.7
Certificate of Change

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
     
 
Kaleidoscope Venture Capital Inc.
(Registrant)
 
 
 
 
 
 
Date: July 15, 2008 By:   /s/ Ron McIntyre  
 

Name: Ron McIntyre
Title: President
 
 
 

 
 
INDEX TO EXHIBITS

No. Description
   
3.1.6
Certificate of Amendment
3.1.7
Certificate of Change
 

1 Year Kaleido Biosciences (CE) Chart

1 Year Kaleido Biosciences (CE) Chart

1 Month Kaleido Biosciences (CE) Chart

1 Month Kaleido Biosciences (CE) Chart

Your Recent History